ASX - Delayed Quote AUD

Healius Limited (HLS.AX)

1.2050 -0.0050 (-0.41%)
At close: 4:10 PM GMT+10
Loading Chart for HLS.AX
DELL
  • Previous Close 1.2100
  • Open 1.2000
  • Bid 1.2000 x 676100
  • Ask 1.2150 x 1520800
  • Day's Range 1.1900 - 1.2200
  • 52 Week Range 1.0900 - 3.0220
  • Volume 2,546,219
  • Avg. Volume 2,704,939
  • Market Cap (intraday) 874.95M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -1.6500
  • Earnings Date Feb 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 7, 2022
  • 1y Target Est 1.25

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

www.healius.com.au

10,500

Full Time Employees

June 30

Fiscal Year Ends

Recent News: HLS.AX

Health Care Roundup: Market Talk

Health Care Roundup: Market Talk

Performance Overview: HLS.AX

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HLS.AX
26.30%
S&P/ASX 200 [XJO]
0.31%

1-Year Return

HLS.AX
57.03%
S&P/ASX 200 [XJO]
2.74%

3-Year Return

HLS.AX
65.84%
S&P/ASX 200 [XJO]
7.10%

5-Year Return

HLS.AX
51.86%
S&P/ASX 200 [XJO]
20.89%

Compare To: HLS.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HLS.AX

Valuation Measures

As of 4/19/2024
  • Market Cap

    874.95M

  • Enterprise Value

    2.40B

  • Trailing P/E

    --

  • Forward P/E

    20.92

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    0.83

  • Enterprise Value/Revenue

    1.42

  • Enterprise Value/EBITDA

    -3.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -57.63%

  • Return on Assets (ttm)

    1.31%

  • Return on Equity (ttm)

    -68.02%

  • Revenue (ttm)

    1.69B

  • Net Income Avi to Common (ttm)

    -984.1M

  • Diluted EPS (ttm)

    -1.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    85.7M

  • Total Debt/Equity (mrq)

    153.80%

  • Levered Free Cash Flow (ttm)

    293.38M

Research Analysis: HLS.AX

Analyst Price Targets

1.00 Low
1.25 Average
1.2050 Current
1.45 High
 

Fair Value

 

People Also Watch